Hutchison China Meditech Share Price (HCM)

3,375.00 0.00 (0.00%) delayed: 1:19PM GMT
Bid price 3,300.00 Open price 3,440.00
Ask price 3,450.00 Prev close 3,375.00
High price 3,450.00 Spread 4.35%
Low price 3,430.00 Volume 208

Register now for FREE live Hutchison China Meditech share prices, Hutchison China Meditech stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Hutchison China Meditech Level 2 Data, indepth research tools and investor commentary for Hutchison China Meditech (HCM) and other London Stock Exchange equities.

Hutchison China Meditech Share Price Chart

Advanced Charts >>

Register now for FREE Hutchison China Meditech share price charts

Hutchison China Meditech Share Price Information

Name Hutchison China Meditech Epic HCM
Sector Pharmaceuticals & Biotechnology ISIN KYG4672N1016
Activites Hutchison China MediTech Limited (Chi-Med) is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets and distributes prescription drugs and consumer health products in China. Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited. Index n/a

Hutchison China Meditech Key Numbers

Latest Share Price (p) 3,375.00 Net Gearing (%) 4.63
Market Capitalisation (£m) 2,239.70 Gross Gearing (%) 18.89
Shares in issue (m) 66.66 Debt Ratio 1.70
P/E Ratio -78.14 Debt-to-Equity Ratio 0.07
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.23
Dividend Yield (%) 0.00 Price to book value 4.62
Dividend cover (x) 0.00 ROCE (%) -4.65
Earning per share (p) -43.00 EPS Growth (%) -315.00
52 week high / low 5,730.00 / 3,185.00 DPS Growth (%) n/a

Hutchison China Meditech Director Deals

Dec.Date Type Director Pos No. of Shares
07/08/2017 BUY Paul Carter NED 724
07/08/2017 BUY Dr Dan Eldar NED 1,900
29/03/2017 TIN Christian Hogg CEO 5,620
20/03/2017 BUY Paul Carter NED 2,800
23/11/2016 SELL Michael Howell RES 10,000

More Hutchison China Meditech Director Deals >>

Hutchison China Meditech Company News

07:00 07/01/2019

Chi-Med Presents at JPM Healthcare Conference

RNS Number : 3418M Hutchison China Meditech Limited 07 January 2019   Press Release   Chi-Med to Present at the 37th Annual JP Morgan Healthcare Conference   London: Monday, January 7, 2019: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM)...

07:00 31/12/2018

Blocklisting Six Monthly Return

RNS Number : 7017L Hutchison China Meditech Limited 31 December 2018   Blocklisting Six Monthly Return   London: Monday, December 31, 2018 : Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) announces the following blocklisting six monthly return:...

07:00 31/12/2018

Total Voting Rights

RNS Number : 7012L Hutchison China Meditech Limited 31 December 2018   Total Voting Rights London: Monday, December 31, 2018: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at December 31, 2018, the issued share...

More Hutchison China Meditech Company News >>

Register now for FREE Hutchison China Meditech company news

Hutchison China Meditech Share Price Discussions

28 days ago

Hutchison China Meditech (HCM)

Hutchison China MediTech Limited ("Chi-Med") is a China-based globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing innovative therapeutics in...

Register now for FREE Hutchison China Meditech share price discussions